Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

DIA

Oct 17, 2013 8:30 AM - Oct 18, 2013 4:00 PM

800 Enterprise Rd Ste 200, Horsham, PA 19044

Global Considerations for Regulatory Strategy Development

Speakers

Mark  Ammann, PharmD

Mark Ammann, PharmD

President, Quantum Regulatory Solutions, LLC, United States

Mark A. Ammann is the owner and President of Catalyst Regulatory Services, LLC. Prior to founding Catalyst, Mark established and built a successful Regulatory Affairs consulting practice at United BioSource Corporation where he served as Vice President of Regulatory Affairs and provided strategic regulatory consulting to a range of clients from start-up pharmaceutical companies to large multinational corporations. He has over 25 years of experience in the pharmaceutical industry and held positions with increasing levels of responsibility within Regulatory Affairs at three major pharmaceutical companies (Novartis, Pharmacia and Pfizer). He received his Doctor of Pharmacy degree from University of Michigan.

Lisa D. Rysso-DeMaggio, RAC

Lisa D. Rysso-DeMaggio, RAC

President, Raquelian Consulting, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.